schliessen

Filtern

 

Bibliotheken

Listeria monocytogenes-associated respiratory infections: a study of 38 consecutive cases

Listeria monocytogenes (Lm) is a foodborne human pathogen responsible for severe infections, including septicaemia, neurolisteriosis, and maternal–foetal and focal infections. Little is known about Lm-associated respiratory tract or lung infections. We conducted a retrospective study of culture-prov... Full description

Journal Title: Clinical microbiology and infection 2018, Vol.24 (12), p.1339.e1-1339.e5
Main Author: Morgand, M
Other Authors: Leclercq, A , Maury, M.M , Bracq-Dieye, H , Thouvenot, P , Vales, G , Lecuit, M , Charlier, C
Format: Electronic Article Electronic Article
Language: English
Subjects:
Quelle: Alma/SFX Local Collection
Publisher: England: Elsevier Ltd
ID: ISSN: 1198-743X
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: cdi_hal_primary_oai_HAL_pasteur_02449011v1
title: Listeria monocytogenes-associated respiratory infections: a study of 38 consecutive cases
format: Article
creator:
  • Morgand, M
  • Leclercq, A
  • Maury, M.M
  • Bracq-Dieye, H
  • Thouvenot, P
  • Vales, G
  • Lecuit, M
  • Charlier, C
subjects:
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti
  • Anti-Bacterial Agents - therapeutic use
  • Bacterial
  • Bacterial Agents
  • Bacteriology
  • complications
  • drug effects
  • drug therapy
  • Empyema
  • Empyema, Pleural - drug therapy
  • Empyema, Pleural - epidemiology
  • Empyema, Pleural - etiology
  • Empyema, Pleural - microbiology
  • epidemiology
  • etiology
  • Female
  • Human health
  • Human health and pathology
  • Humans
  • Immunosuppression
  • Infectious diseases
  • isolation & purification
  • Life Sciences
  • Listeria monocytogenes
  • Listeria monocytogenes - drug effects
  • Listeria monocytogenes - isolation & purification
  • Listeriosis
  • Listeriosis - complications
  • Listeriosis - drug therapy
  • Listeriosis - epidemiology
  • Listeriosis - microbiology
  • Lung Diseases
  • Lung Diseases - drug therapy
  • Lung Diseases - epidemiology
  • Lung Diseases - etiology
  • Lung Diseases - microbiology
  • Male
  • microbiology
  • Microbiology and Parasitology
  • Middle Aged
  • over
  • Parasitology
  • pathology
  • Pleural
  • Pleural effusion
  • Pleuropneumonia
  • Pleuropneumonia - drug therapy
  • Pleuropneumonia - epidemiology
  • Pleuropneumonia - etiology
  • Pleuropneumonia - microbiology
  • Pneumonia
  • Pneumonia, Bacterial - drug therapy
  • Pneumonia, Bacterial - epidemiology
  • Pneumonia, Bacterial - etiology
  • Pneumonia, Bacterial - microbiology
  • Respiratory Tract Infections
  • Respiratory Tract Infections - drug therapy
  • Respiratory Tract Infections - epidemiology
  • Respiratory Tract Infections - etiology
  • Respiratory Tract Infections - microbiology
  • Retrospective Studies
  • Sepsis
  • Sepsis - drug therapy
  • Sepsis - epidemiology
  • Sepsis - etiology
  • Sepsis - microbiology
  • therapeutic use
ispartof: Clinical microbiology and infection, 2018, Vol.24 (12), p.1339.e1-1339.e5
description: Listeria monocytogenes (Lm) is a foodborne human pathogen responsible for severe infections, including septicaemia, neurolisteriosis, and maternal–foetal and focal infections. Little is known about Lm-associated respiratory tract or lung infections. We conducted a retrospective study of culture-proven cases of Lm pleural infections and pneumonia reported to the French National Reference Centre for Listeria from January 1993 to August 2016. Thirty-eight consecutive patients with pleural infection (n = 32), pneumonia (n = 5), or both (n = 1) were studied; 71% of these were men. Median age was 72 (range 29–90). Two patients presented with concomitant neurolisteriosis. All patients but one reported at least one immunosuppressive condition (97%), with a median number of 2 (range 0–5), including 29% (8/28) with current exposure to immunosuppressive therapy and 50% (17/34) with ongoing neoplasia; 75% (21/28) reported previous pleural or pulmonary disease. Antibiotic therapy mostly consisted in amoxicillin (72%) associated with aminoglycoside in 32%. Chest-tube drainage was performed in 7/19 patients with empyema (37%); 25% of the patients (7/30) required intensive care management. In-hospital mortality reached 35% and occurred after a median time interval of 4 days (range 1–33 days). Three patients had recurrence of empyema (time interval of 1 week to 4 months after treatment completion). Altogether, only 13/31 patients (42%) diagnosed with Lm respiratory infection experienced an uneventful outcome at 2-year follow-up. Lm is a rare but severe cause of pneumonia and pleural infection in older immunocompromised patients, requiring prompt diagnosis and adequate management and follow-up.
language: eng
source: Alma/SFX Local Collection
identifier: ISSN: 1198-743X
fulltext: fulltext
issn:
  • 1198-743X
  • 1469-0691
url: Link


@attributes
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
RANK2.5760777
LOCALfalse
PrimoNMBib
record
control
sourceidproquest_opena
recordidTN_cdi_hal_primary_oai_HAL_pasteur_02449011v1
sourceformatXML
sourcesystemPC
sourcerecordid2014956764
originalsourceidFETCH-LOGICAL-1659t-c9494ccc1e1e9d8043c23f2b200a99bff252fb5b9d3ec7625ef11a0213f0e5d63
addsrcrecordideNqNksFuEzEQhlcIREvhAbigPXLZdMb2Oms4VRWQShFcQIKT5bXH4ChZL_Zuqrw9rtJW4gI52bL-_9OM9VXVa4QFAsrLzcLuwoIBdgvgCwD-pDpHIVUDUuHTckfVNUvBv59VL3LeAADjXDyvzphqhYK2O69-rEOeKAVT7-IQ7WGKP2mg3Jicow1mIlcnymNIZorpUIfBk51CHPK72tR5mt2hjr7mXW3LG9l5CnuqrcmUX1bPvNlmenV_XlTfPn74er1q1l8-3VxfrRuUrZoaq4QS1lokJOU6ENwy7lnPAIxSvfesZb5ve-U42aVkLXlEAwy5B2qd5BfV6siNIw0mJNJjCjuTDjqaoN1Ak45OM2SamFRAQJx6L6UwcolctZwb48FTDyeiytynoG5OQXHVncL6_D-WIzeP-tZrADwF2ByBv8z2L9bqaq1HU4SYkwYmiiOIeyz5t8f8mOLvmfKkdyFb2m7NQHHOuhgoVCuXUpQoHqM2xZwT-Uc-gr6TVm90kfau0mngZV5eOm_u8XO_I_fYeLC0BN4fA1Q82gdKOttAgyVXPsOW7WP4B_4PKMP5cA
sourcetypeOpen Access Repository
isCDItrue
recordtypearticle
pqid2014956764
display
typearticle
titleListeria monocytogenes-associated respiratory infections: a study of 38 consecutive cases
sourceAlma/SFX Local Collection
creatorMorgand, M ; Leclercq, A ; Maury, M.M ; Bracq-Dieye, H ; Thouvenot, P ; Vales, G ; Lecuit, M ; Charlier, C
creatorcontribMorgand, M ; Leclercq, A ; Maury, M.M ; Bracq-Dieye, H ; Thouvenot, P ; Vales, G ; Lecuit, M ; Charlier, C
descriptionListeria monocytogenes (Lm) is a foodborne human pathogen responsible for severe infections, including septicaemia, neurolisteriosis, and maternal–foetal and focal infections. Little is known about Lm-associated respiratory tract or lung infections. We conducted a retrospective study of culture-proven cases of Lm pleural infections and pneumonia reported to the French National Reference Centre for Listeria from January 1993 to August 2016. Thirty-eight consecutive patients with pleural infection (n = 32), pneumonia (n = 5), or both (n = 1) were studied; 71% of these were men. Median age was 72 (range 29–90). Two patients presented with concomitant neurolisteriosis. All patients but one reported at least one immunosuppressive condition (97%), with a median number of 2 (range 0–5), including 29% (8/28) with current exposure to immunosuppressive therapy and 50% (17/34) with ongoing neoplasia; 75% (21/28) reported previous pleural or pulmonary disease. Antibiotic therapy mostly consisted in amoxicillin (72%) associated with aminoglycoside in 32%. Chest-tube drainage was performed in 7/19 patients with empyema (37%); 25% of the patients (7/30) required intensive care management. In-hospital mortality reached 35% and occurred after a median time interval of 4 days (range 1–33 days). Three patients had recurrence of empyema (time interval of 1 week to 4 months after treatment completion). Altogether, only 13/31 patients (42%) diagnosed with Lm respiratory infection experienced an uneventful outcome at 2-year follow-up. Lm is a rare but severe cause of pneumonia and pleural infection in older immunocompromised patients, requiring prompt diagnosis and adequate management and follow-up.
identifier
0ISSN: 1198-743X
1EISSN: 1469-0691
2DOI: 10.1016/j.cmi.2018.03.003
3PMID: 29549058
languageeng
publisherEngland: Elsevier Ltd
subjectAdult ; Aged ; Aged, 80 and over ; Anti ; Anti-Bacterial Agents - therapeutic use ; Bacterial ; Bacterial Agents ; Bacteriology ; complications ; drug effects ; drug therapy ; Empyema ; Empyema, Pleural - drug therapy ; Empyema, Pleural - epidemiology ; Empyema, Pleural - etiology ; Empyema, Pleural - microbiology ; epidemiology ; etiology ; Female ; Human health ; Human health and pathology ; Humans ; Immunosuppression ; Infectious diseases ; isolation & purification ; Life Sciences ; Listeria monocytogenes ; Listeria monocytogenes - drug effects ; Listeria monocytogenes - isolation & purification ; Listeriosis ; Listeriosis - complications ; Listeriosis - drug therapy ; Listeriosis - epidemiology ; Listeriosis - microbiology ; Lung Diseases ; Lung Diseases - drug therapy ; Lung Diseases - epidemiology ; Lung Diseases - etiology ; Lung Diseases - microbiology ; Male ; microbiology ; Microbiology and Parasitology ; Middle Aged ; over ; Parasitology ; pathology ; Pleural ; Pleural effusion ; Pleuropneumonia ; Pleuropneumonia - drug therapy ; Pleuropneumonia - epidemiology ; Pleuropneumonia - etiology ; Pleuropneumonia - microbiology ; Pneumonia ; Pneumonia, Bacterial - drug therapy ; Pneumonia, Bacterial - epidemiology ; Pneumonia, Bacterial - etiology ; Pneumonia, Bacterial - microbiology ; Respiratory Tract Infections ; Respiratory Tract Infections - drug therapy ; Respiratory Tract Infections - epidemiology ; Respiratory Tract Infections - etiology ; Respiratory Tract Infections - microbiology ; Retrospective Studies ; Sepsis ; Sepsis - drug therapy ; Sepsis - epidemiology ; Sepsis - etiology ; Sepsis - microbiology ; therapeutic use
ispartofClinical microbiology and infection, 2018, Vol.24 (12), p.1339.e1-1339.e5
rights
02018 European Society of Clinical Microbiology and Infectious Diseases
1Copyright © 2018 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
2Attribution - NonCommercial
lds50peer_reviewed
oafree_for_read
citesFETCH-LOGICAL-1659t-c9494ccc1e1e9d8043c23f2b200a99bff252fb5b9d3ec7625ef11a0213f0e5d63
orcidid0000-0003-3778-7313
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
thumbnail$$Usyndetics_thumb_exl
backlink
0$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29549058$$D View this record in MEDLINE/PubMed
1$$Uhttps://hal-pasteur.archives-ouvertes.fr/pasteur-02449011$$DView record in HAL
search
creatorcontrib
0Morgand, M
1Leclercq, A
2Maury, M.M
3Bracq-Dieye, H
4Thouvenot, P
5Vales, G
6Lecuit, M
7Charlier, C
title
0Listeria monocytogenes-associated respiratory infections: a study of 38 consecutive cases
1Clinical microbiology and infection
addtitleClin Microbiol Infect
descriptionListeria monocytogenes (Lm) is a foodborne human pathogen responsible for severe infections, including septicaemia, neurolisteriosis, and maternal–foetal and focal infections. Little is known about Lm-associated respiratory tract or lung infections. We conducted a retrospective study of culture-proven cases of Lm pleural infections and pneumonia reported to the French National Reference Centre for Listeria from January 1993 to August 2016. Thirty-eight consecutive patients with pleural infection (n = 32), pneumonia (n = 5), or both (n = 1) were studied; 71% of these were men. Median age was 72 (range 29–90). Two patients presented with concomitant neurolisteriosis. All patients but one reported at least one immunosuppressive condition (97%), with a median number of 2 (range 0–5), including 29% (8/28) with current exposure to immunosuppressive therapy and 50% (17/34) with ongoing neoplasia; 75% (21/28) reported previous pleural or pulmonary disease. Antibiotic therapy mostly consisted in amoxicillin (72%) associated with aminoglycoside in 32%. Chest-tube drainage was performed in 7/19 patients with empyema (37%); 25% of the patients (7/30) required intensive care management. In-hospital mortality reached 35% and occurred after a median time interval of 4 days (range 1–33 days). Three patients had recurrence of empyema (time interval of 1 week to 4 months after treatment completion). Altogether, only 13/31 patients (42%) diagnosed with Lm respiratory infection experienced an uneventful outcome at 2-year follow-up. Lm is a rare but severe cause of pneumonia and pleural infection in older immunocompromised patients, requiring prompt diagnosis and adequate management and follow-up.
subject
0Adult
1Aged
2Aged, 80 and over
3Anti
4Anti-Bacterial Agents - therapeutic use
5Bacterial
6Bacterial Agents
7Bacteriology
8complications
9drug effects
10drug therapy
11Empyema
12Empyema, Pleural - drug therapy
13Empyema, Pleural - epidemiology
14Empyema, Pleural - etiology
15Empyema, Pleural - microbiology
16epidemiology
17etiology
18Female
19Human health
20Human health and pathology
21Humans
22Immunosuppression
23Infectious diseases
24isolation & purification
25Life Sciences
26Listeria monocytogenes
27Listeria monocytogenes - drug effects
28Listeria monocytogenes - isolation & purification
29Listeriosis
30Listeriosis - complications
31Listeriosis - drug therapy
32Listeriosis - epidemiology
33Listeriosis - microbiology
34Lung Diseases
35Lung Diseases - drug therapy
36Lung Diseases - epidemiology
37Lung Diseases - etiology
38Lung Diseases - microbiology
39Male
40microbiology
41Microbiology and Parasitology
42Middle Aged
43over
44Parasitology
45pathology
46Pleural
47Pleural effusion
48Pleuropneumonia
49Pleuropneumonia - drug therapy
50Pleuropneumonia - epidemiology
51Pleuropneumonia - etiology
52Pleuropneumonia - microbiology
53Pneumonia
54Pneumonia, Bacterial - drug therapy
55Pneumonia, Bacterial - epidemiology
56Pneumonia, Bacterial - etiology
57Pneumonia, Bacterial - microbiology
58Respiratory Tract Infections
59Respiratory Tract Infections - drug therapy
60Respiratory Tract Infections - epidemiology
61Respiratory Tract Infections - etiology
62Respiratory Tract Infections - microbiology
63Retrospective Studies
64Sepsis
65Sepsis - drug therapy
66Sepsis - epidemiology
67Sepsis - etiology
68Sepsis - microbiology
69therapeutic use
issn
01198-743X
11469-0691
fulltexttrue
rsrctypearticle
creationdate2018
recordtypearticle
recordideNqNksFuEzEQhlcIREvhAbigPXLZdMb2Oms4VRWQShFcQIKT5bXH4ChZL_Zuqrw9rtJW4gI52bL-_9OM9VXVa4QFAsrLzcLuwoIBdgvgCwD-pDpHIVUDUuHTckfVNUvBv59VL3LeAADjXDyvzphqhYK2O69-rEOeKAVT7-IQ7WGKP2mg3Jicow1mIlcnymNIZorpUIfBk51CHPK72tR5mt2hjr7mXW3LG9l5CnuqrcmUX1bPvNlmenV_XlTfPn74er1q1l8-3VxfrRuUrZoaq4QS1lokJOU6ENwy7lnPAIxSvfesZb5ve-U42aVkLXlEAwy5B2qd5BfV6siNIw0mJNJjCjuTDjqaoN1Ak45OM2SamFRAQJx6L6UwcolctZwb48FTDyeiytynoG5OQXHVncL6_D-WIzeP-tZrADwF2ByBv8z2L9bqaq1HU4SYkwYmiiOIeyz5t8f8mOLvmfKkdyFb2m7NQHHOuhgoVCuXUpQoHqM2xZwT-Uc-gr6TVm90kfau0mngZV5eOm_u8XO_I_fYeLC0BN4fA1Q82gdKOttAgyVXPsOW7WP4B_4PKMP5cA
startdate201812
enddate201812
creator
0Morgand, M
1Leclercq, A
2Maury, M.M
3Bracq-Dieye, H
4Thouvenot, P
5Vales, G
6Lecuit, M
7Charlier, C
general
0Elsevier Ltd
1Elsevier for the European Society of Clinical Microbiology and Infectious Diseases
scope
06I.
1AAFTH
2CGR
3CUY
4CVF
5ECM
6EIF
7NPM
8AAYXX
9CITATION
107X8
111XC
12VOOES
13BOBZL
14CLFQK
orcididhttps://orcid.org/0000-0003-3778-7313
sort
creationdate201812
titleListeria monocytogenes-associated respiratory infections: a study of 38 consecutive cases
authorMorgand, M ; Leclercq, A ; Maury, M.M ; Bracq-Dieye, H ; Thouvenot, P ; Vales, G ; Lecuit, M ; Charlier, C
facets
frbrtype5
frbrgroupidcdi_FETCH-LOGICAL-1659t-c9494ccc1e1e9d8043c23f2b200a99bff252fb5b9d3ec7625ef11a0213f0e5d63
rsrctypearticles
prefilterarticles
languageeng
creationdate2018
topic
0Adult
1Aged
2Aged, 80 and over
3Anti
4Anti-Bacterial Agents - therapeutic use
5Bacterial
6Bacterial Agents
7Bacteriology
8complications
9drug effects
10drug therapy
11Empyema
12Empyema, Pleural - drug therapy
13Empyema, Pleural - epidemiology
14Empyema, Pleural - etiology
15Empyema, Pleural - microbiology
16epidemiology
17etiology
18Female
19Human health
20Human health and pathology
21Humans
22Immunosuppression
23Infectious diseases
24isolation & purification
25Life Sciences
26Listeria monocytogenes
27Listeria monocytogenes - drug effects
28Listeria monocytogenes - isolation & purification
29Listeriosis
30Listeriosis - complications
31Listeriosis - drug therapy
32Listeriosis - epidemiology
33Listeriosis - microbiology
34Lung Diseases
35Lung Diseases - drug therapy
36Lung Diseases - epidemiology
37Lung Diseases - etiology
38Lung Diseases - microbiology
39Male
40microbiology
41Microbiology and Parasitology
42Middle Aged
43over
44Parasitology
45pathology
46Pleural
47Pleural effusion
48Pleuropneumonia
49Pleuropneumonia - drug therapy
50Pleuropneumonia - epidemiology
51Pleuropneumonia - etiology
52Pleuropneumonia - microbiology
53Pneumonia
54Pneumonia, Bacterial - drug therapy
55Pneumonia, Bacterial - epidemiology
56Pneumonia, Bacterial - etiology
57Pneumonia, Bacterial - microbiology
58Respiratory Tract Infections
59Respiratory Tract Infections - drug therapy
60Respiratory Tract Infections - epidemiology
61Respiratory Tract Infections - etiology
62Respiratory Tract Infections - microbiology
63Retrospective Studies
64Sepsis
65Sepsis - drug therapy
66Sepsis - epidemiology
67Sepsis - etiology
68Sepsis - microbiology
69therapeutic use
toplevel
0peer_reviewed
1online_resources
creatorcontrib
0Morgand, M
1Leclercq, A
2Maury, M.M
3Bracq-Dieye, H
4Thouvenot, P
5Vales, G
6Lecuit, M
7Charlier, C
collection
0ScienceDirect Open Access Titles
1Elsevier:ScienceDirect:Open Access
2Medline
3MEDLINE
4MEDLINE (Ovid)
5MEDLINE
6MEDLINE
7PubMed
8CrossRef
9MEDLINE - Academic
10Hyper Article en Ligne (HAL)
11Hyper Article en Ligne (HAL) (Open Access)
12OpenAIRE (Open Access)
13OpenAIRE
jtitleClinical microbiology and infection
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
au
0Morgand, M
1Leclercq, A
2Maury, M.M
3Bracq-Dieye, H
4Thouvenot, P
5Vales, G
6Lecuit, M
7Charlier, C
formatjournal
genrearticle
ristypeJOUR
atitleListeria monocytogenes-associated respiratory infections: a study of 38 consecutive cases
jtitleClinical microbiology and infection
addtitleClin Microbiol Infect
date2018-12
risdate2018
volume24
issue12
spage1339.e1
epage1339.e5
pages1339.e1-1339.e5
issn1198-743X
eissn1469-0691
abstractListeria monocytogenes (Lm) is a foodborne human pathogen responsible for severe infections, including septicaemia, neurolisteriosis, and maternal–foetal and focal infections. Little is known about Lm-associated respiratory tract or lung infections. We conducted a retrospective study of culture-proven cases of Lm pleural infections and pneumonia reported to the French National Reference Centre for Listeria from January 1993 to August 2016. Thirty-eight consecutive patients with pleural infection (n = 32), pneumonia (n = 5), or both (n = 1) were studied; 71% of these were men. Median age was 72 (range 29–90). Two patients presented with concomitant neurolisteriosis. All patients but one reported at least one immunosuppressive condition (97%), with a median number of 2 (range 0–5), including 29% (8/28) with current exposure to immunosuppressive therapy and 50% (17/34) with ongoing neoplasia; 75% (21/28) reported previous pleural or pulmonary disease. Antibiotic therapy mostly consisted in amoxicillin (72%) associated with aminoglycoside in 32%. Chest-tube drainage was performed in 7/19 patients with empyema (37%); 25% of the patients (7/30) required intensive care management. In-hospital mortality reached 35% and occurred after a median time interval of 4 days (range 1–33 days). Three patients had recurrence of empyema (time interval of 1 week to 4 months after treatment completion). Altogether, only 13/31 patients (42%) diagnosed with Lm respiratory infection experienced an uneventful outcome at 2-year follow-up. Lm is a rare but severe cause of pneumonia and pleural infection in older immunocompromised patients, requiring prompt diagnosis and adequate management and follow-up.
copEngland
pubElsevier Ltd
pmid29549058
doi10.1016/j.cmi.2018.03.003
orcididhttps://orcid.org/0000-0003-3778-7313
oafree_for_read